Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Current Leases (2017 - 2025)

Jaguar Health (JAGX) has disclosed Current Leases for 9 consecutive years, with $192000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases fell 35.79% to $192000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $192000.0 through Dec 2025, down 35.79% year-over-year, with the annual reading at $192000.0 for FY2025, 35.79% down from the prior year.
  • Current Leases for Q4 2025 was $192000.0 at Jaguar Health, down from $226000.0 in the prior quarter.
  • The five-year high for Current Leases was $526000.0 in Q3 2023, with the low at $192000.0 in Q4 2025.
  • Average Current Leases over 5 years is $353526.3, with a median of $348000.0 recorded in 2023.
  • The sharpest move saw Current Leases soared 101.25% in 2022, then tumbled 41.79% in 2025.
  • Over 5 years, Current Leases stood at $240000.0 in 2021, then soared by 101.25% to $483000.0 in 2022, then decreased by 27.95% to $348000.0 in 2023, then dropped by 14.08% to $299000.0 in 2024, then plummeted by 35.79% to $192000.0 in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $192000.0, $226000.0, and $256000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.